MedTrace Logo

Fractionated Stereotactic Radiosurgery for Large Brain Metastases

NCT02054689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-28

Study results available
· View outcomes & findings →

Summary

This is a research trial that seeks to break up the total radiation dose into multiple smaller radiation treatments, termed fractionated stereotactic radiosurgery (FSRS) which may make the treatment feasible. Fractionated sterotatcic radiation, the risks of FSRS, and possible costs will be described later in this document. This clinical trial is for people who have had no prior whole brain radiation.

Conditions

  • Large Brain Mets

Interventions

RADIATION

Fractionated Stereotactic Radiosurgery

SRS SBRT CyberKnife Trilogy True Beam Radiosurgery

Sponsors & Collaborators

  • Steven Burton

    lead OTHER

Principal Investigators

  • Steve Burton, MD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-16
Primary Completion
2017-11-20
Completion
2023-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02054689 on ClinicalTrials.gov